Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Effect on Rocuronium Dose in Prostatectomy
NCT04013243Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Apr 2019
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in prostate cancer (PCa) comparing Magnesium Sulfate Group with Placebo Group (2 arms). Primary endpoint: Total amount of rocuronium administered at 48 hours. Started Apr 2019; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04013243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04013243.